Home › Health › The UK’s legal cannabis market is booming – so why can’t...
Health

The UK’s legal cannabis market is booming – so why can’t this talented artist get any to treat his epilepsy? | Kojo Koram

Key Points

Companies have rushed to supply the drug as a wellness treatment, but patients with serious illnesses aren’t able to get NHS prescriptionsIn 2022, a prodigiously talented young artist named Louis Petit was preparing to return to the UK, having been effectively exiled in the Netherlands as a teenager so he could access the medical cannabis he needed to control his epilepsy. Six years earlier, Louis, then 12, had been diagnosed with a rare form of the neurological disease when medical cannabis...

Companies have rushed to supply the drug as a wellness treatment, but patients with serious illnesses aren’t able to get NHS prescriptions

In 2022, a prodigiously talented young artist named Louis Petit was preparing to return to the UK, having been effectively exiled in the Netherlands as a teenager so he could access the medical cannabis he needed to control his epilepsy. Six years earlier, Louis, then 12, had been diagnosed with a rare form of the neurological disease when medical cannabis was still illegal in the UK.

But in Rotterdam, where it was legal, doctors helped him discover that a medical cannabis oil called Bedrolite, in combination with the right mix of anti-epileptic treatment, could slow and eventually stop his seizures. This was something his neurologists in the UK had previously considered impossible.

Dr Kojo Koram is professor of law and political economy at Loughborough University and the author of The Next Fix: The Winners and Losers in the Future of Drugs

Continue reading...
UK (LOCATION) Kojo Koram Companies (ORG) NHS (ORG) Louis Petit (PERSON) Netherlands (LOCATION) Louis (LOCATION) Rotterdam (LOCATION) Bedrolite (ORG) Dr Kojo Koram (PERSON) Loughborough University (ORG) the Future of Drugs Continue (ORG)
Originally published by The Guardian Politics Read original →